Autolus exec trades 20K ADSs, sells 6,713

Autolus Therapeutics’ U.S. CCO & Country General Manager exercised equity awards for 20,000 ADSs and sold 6,713 ADSs in early September 2026.

Rhea-AI Filing Summary

Autolus Therapeutics plc (AUTL) reported insider activity by U.S. CCO & Country General Manager Cintia Piccina involving both equity awards and a sale of shares. On September 1, 2026, she completed a derivative transaction relating to 20,000 Restricted Share Units (RSUs), with each RSU representing a contingent right to receive one American Depositary Share (ADS); these RSUs vest in four equal annual installments commencing on September 1, 2026. A related entry records the acquisition of 20,000 ADSs on the same date at $2.35 per ADS following the derivative exercise, and she held 60,000 RSUs afterward. On September 2, 2026, she sold 6,713 ADSs in an open-market or private transaction at $2.336 per ADS, and no Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Piccina Cintia

Role U.S. CCO & Country Gen Manager

Sold 6,713 shs ($16K)

Approx. gross sale proceeds $16K

Type	Security	Shares	Price	Value
Sale	American Depositary Shares	6,713	$2.336	$16K
Exercise	Restricted Share Units F1, F2	20,000	$0.00	$0.00
Exercise	American Depositary Shares	20,000	$2.35	$47K

Holdings After Transaction: Restricted Share Units — 60,000 contracts (Direct); American Depositary Shares — 13,287 shares (Direct)

Footnotes (2)

1. F1. Each RSU represents a contingent right to receive one Issuer American Depositary Share.
2. F2. The restricted share units ("RSUs") vest in four equal annual installments commencing on September 1, 2026.

Key Figures

ADSs sold: 6,713 American Depositary Shares Sale price per ADS: $2.336 per American Depositary Share ADSs acquired via derivative exercise: 20,000 American Depositary Shares +3 more

6 metrics

ADSs sold 6,713 American Depositary Shares Sale reported for September 2, 2026 by Cintia Piccina

Sale price per ADS $2.336 per American Depositary Share September 2, 2026 open-market or private sale

ADSs acquired via derivative exercise 20,000 American Depositary Shares Acquisition on September 1, 2026 following derivative exercise/conversion

Acquisition price per ADS $2.35 per American Depositary Share ADSs acquired on September 1, 2026 from derivative exercise

RSUs in derivative transaction 20,000 Restricted Share Units RSU-related derivative transaction on September 1, 2026

RSUs held after transaction 60,000 Restricted Share Units Direct RSU holdings reported following the September 1, 2026 transaction

Key Terms

American Depositary Shares, Restricted Share Units, contingent right, vest in four equal annual installments

4 terms

American Depositary Shares financial

"Each RSU represents a contingent right to receive one Issuer American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Restricted Share Units financial

"The restricted share units ("RSUs") vest in four equal annual installments"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"Each RSU represents a contingent right to receive one Issuer American Depositary Share."

vest in four equal annual installments financial

"The restricted share units ("RSUs") vest in four equal annual installments"

FAQ

What insider transactions did AUTL executive Cintia Piccina report on this Form 4?

She reported a derivative transaction relating to 20,000 RSUs tied to Autolus American Depositary Shares on September 1, 2026, a related acquisition of 20,000 ADSs at $2.35 per ADS, and a sale of 6,713 ADSs at $2.336 per ADS on September 2, 2026.

How many Autolus (AUTL) shares did the insider sell, and at what price?

On September 2, 2026, Cintia Piccina sold 6,713 American Depositary Shares of Autolus at a price of $2.336 per ADS in a sale reported as occurring in the open market or a private transaction.

What equity did the AUTL insider acquire through derivative activity?

On September 1, 2026, a derivative exercise/conversion related to 20,000 Restricted Share Units resulted in the acquisition of 20,000 American Depositary Shares at $2.35 per ADS. Each RSU represents a contingent right to receive one ADS of Autolus Therapeutics plc.

What RSU holdings did the AUTL insider report after these transactions?

Following the September 1, 2026 derivative transaction, Cintia Piccina reported holding 60,000 Restricted Share Units directly. The RSUs vest in four equal annual installments commencing on September 1, 2026, with each RSU convertible into one American Depositary Share of Autolus.

Were the AUTL insider’s transactions made under a Rule 10b5-1 trading plan?

No. The filing indicates no Rule 10b5-1 trading plan for these transactions, meaning the reported RSU-related derivative transactions and the sale of 6,713 American Depositary Shares were not affirmed as being executed under a pre-arranged Rule 10b5-1 trading plan.

What is the vesting schedule of the AUTL Restricted Share Units reported?

The filing states that the Restricted Share Units vest in four equal annual installments, commencing on September 1, 2026. Each vesting RSU represents a contingent right to receive one Issuer American Depositary Share of Autolus Therapeutics plc upon settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 04:55 PM Accepted by SEC EDGAR 09/03/2026 - 04:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Piccina Cintia

(Last) (First) (Middle)

THE MEDIAWORKS, WHITE CITY

C/O AUTOLUS THERAPEUTICS PLC

(Street)

LONDON W12 7FP

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Autolus Therapeutics plc [ AUTL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	U.S. CCO & Country Gen Manager

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	09/01/2026		M		20,000	A	$2.35	20,000	D
American Depositary Shares	09/02/2026		S		6,713	D	$2.336	13,287	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	09/01/2026		M			20,000	(2)	(2)	American Depositary Shares	20,000	$0	60,000	D

Explanation of Responses:

1. Each RSU represents a contingent right to receive one Issuer American Depositary Share.

2. The restricted share units ("RSUs") vest in four equal annual installments commencing on September 1, 2026.

	/s/ Cintia Piccina	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)